Grantham, Mayo, Van Otterloo & Co (GMO)’s Diversified Healthcare Trust DHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-23,775
Closed -$85.1K 620
2025
Q2
$85.1K Hold
23,775
﹤0.01% 602
2025
Q1
$57.1K Sell
23,775
-26,842
-53% -$66.2K ﹤0.01% 608
2024
Q4
$116K Hold
50,617
﹤0.01% 566
2024
Q3
$212K Hold
50,617
﹤0.01% 547
2024
Q2
$154K Sell
50,617
-5,907
-10% -$15K ﹤0.01% 518
2024
Q1
$139K Hold
56,524
﹤0.01% 506
2023
Q4
$211K Sell
56,524
-46,476
-45% -$109K ﹤0.01% 468
2023
Q3
$200K Sell
103,000
-349,456
-77% -$886K ﹤0.01% 553
2023
Q2
$1.02M Buy
452,456
+58,156
+15% +$83.5K ﹤0.01% 490
2023
Q1
$532K Sell
394,300
-56,900
-13% -$58.8K ﹤0.01% 555
2022
Q4
$292K Buy
451,200
+53,900
+14% +$53.2K ﹤0.01% 635
2022
Q3
$393K Sell
397,300
-209,500
-35% -$336K ﹤0.01% 602
2022
Q2
$1.1M Buy
606,800
+194,800
+47% +$445K 0.01% 508
2022
Q1
$1.32M Buy
+412,000
New +$1.26M 0.01% 491

Other funds holding DHC

Grantham, Mayo, Van Otterloo & Co (GMO)'s DHC Position: Q3 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Diversified Healthcare Trust (DHC) in Q3 2025, closing a stake of 23,775 shares — an estimated $85.1K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in DHC in Q1 2022 and held it in 14 quarters. The position peaked at $1.32M in Q1 2022. 204 funds tracked by Wall St. Rank hold DHC as of Q3 2025.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Diversified Healthcare Trust position as of Q3 2025 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 23,775 Diversified Healthcare Trust shares in Q3 2025, an estimated $85.1K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Diversified Healthcare Trust in Q1 2022 and held it in 14 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Diversified Healthcare Trust position peaked at $1.32M in Q1 2022.
  • 204 funds tracked by Wall St. Rank held Diversified Healthcare Trust as of Q3 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2025, filed 13 Nov 2025.